HIV Detail Information
Zalcitabine (ID: DG00888) Resistance Data of HIV
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||||||||||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||||||||||||
Key Molecule: Gag-Pol polyprotein (POL) | ||||||||||||||
Resistant Disease | Human immunodeficiency virus infection [ICD-11: 1C62.0] | |||||||||||||
Molecule Alteration |
|
|||||||||||||
Resistant Drug | Zalcitabine | |||||||||||||
Experimental Note | Identified from the Human Clinical Data | |||||||||||||
Mechanism Description | Resistance to zalcitabine usually arises from a series of mutations within the HIV pol gene and develops less frequently than resistance to zidovudine. | |||||||||||||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.